IRIS
DEL POETA, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 68.098
EU - Europa 5.299
AS - Asia 2.975
SA - Sud America 133
Continente sconosciuto - Info sul continente non disponibili 16
AF - Africa 11
OC - Oceania 8
Totale 76.540
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 68.057
DE - Germania 1.722
SG - Singapore 1.307
UA - Ucraina 1.007
CN - Cina 857
IE - Irlanda 630
RU - Federazione Russa 468
IT - Italia 422
HK - Hong Kong 420
GB - Regno Unito 337
KR - Corea 214
FI - Finlandia 212
SE - Svezia 210
FR - Francia 148
BR - Brasile 100
JP - Giappone 42
NL - Olanda 38
CA - Canada 27
UZ - Uzbekistan 26
BE - Belgio 25
AT - Austria 20
VN - Vietnam 17
PL - Polonia 16
TR - Turchia 14
CL - Cile 12
CZ - Repubblica Ceca 12
IN - India 12
PH - Filippine 11
EU - Europa 9
ID - Indonesia 8
A2 - ???statistics.table.value.countryCode.A2??? 7
PE - Perù 7
TH - Thailandia 7
AR - Argentina 6
AU - Australia 6
CH - Svizzera 6
DM - Dominica 6
EG - Egitto 5
IR - Iran 5
MX - Messico 5
ES - Italia 4
IL - Israele 4
KG - Kirghizistan 4
LT - Lituania 4
MY - Malesia 4
NO - Norvegia 4
PK - Pakistan 4
RO - Romania 4
ZA - Sudafrica 4
BD - Bangladesh 3
PT - Portogallo 3
VE - Venezuela 3
AL - Albania 2
AZ - Azerbaigian 2
CO - Colombia 2
DK - Danimarca 2
EC - Ecuador 2
GR - Grecia 2
JO - Giordania 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
MN - Mongolia 2
NZ - Nuova Zelanda 2
QA - Qatar 2
TW - Taiwan 2
BG - Bulgaria 1
CR - Costa Rica 1
HN - Honduras 1
IQ - Iraq 1
PA - Panama 1
SA - Arabia Saudita 1
SN - Senegal 1
TN - Tunisia 1
UY - Uruguay 1
Totale 76.540
Salva come PNG Salva come JPEG
Città #
Woodbridge 22.016
Wilmington 17.834
Houston 15.511
Fairfield 2.049
Ann Arbor 1.727
Chandler 1.132
Singapore 1.071
Ashburn 1.035
Jacksonville 917
Seattle 835
Cambridge 711
Dublin 619
Dearborn 519
Medford 465
Hong Kong 409
Beijing 354
Santa Clara 260
New York 220
Lawrence 219
Zhengzhou 173
Rome 110
Mülheim 106
San Diego 103
Moscow 84
Menlo Park 62
Milan 56
University Park 49
Hefei 45
Council Bluffs 44
Boardman 42
Nanjing 42
Mountain View 41
Norwalk 40
Munich 35
London 34
Creede 32
Shanghai 32
Falls Church 29
Nuremberg 29
Palo Alto 28
Verona 27
Kunming 26
Redwood City 26
Guangzhou 23
Brussels 22
Saint Petersburg 17
Toronto 17
Detroit 16
Nürnberg 15
Chicago 13
Helsinki 13
Brno 12
Hangzhou 12
Hanoi 12
Los Angeles 12
Seoul 12
Bologna 11
Chengdu 11
Groningen 10
Indiana 10
Nanchang 10
Kilburn 9
Phoenix 9
Redmond 9
San Mateo 9
São Paulo 9
Hebei 8
Hounslow 8
Shenyang 8
Center 7
Chiswick 7
Frankfurt am Main 7
Fuzhou 7
Innsbruck 7
Jinan 7
Lima 7
Manila 7
Prescot 7
Jakarta 6
Kraków 6
Padova 6
Roseau 6
San Francisco 6
Tokyo 6
Berlin 5
Changsha 5
Chiang Mai 5
Diyarbakır 5
Dong Ket 5
Florence 5
Leawood 5
Louisville 5
Naples 5
Vienna 5
Auburn Hills 4
Belo Horizonte 4
Izmir 4
Kuala Lumpur 4
Montreal 4
Mumbai 4
Totale 69.688
Salva come PNG Salva come JPEG
Nome #
Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia 559
Femoral catheters: safety and efficacy in peripheral blood stem cell collection 480
Enumeration of CD34+ hematopoietic progenitor cells for clinical transplantation: comparison of three different methods 480
Enumeration of CD34+ hematopoietic progenitor cells for clinical transplantation: comparison of three different methods 470
A microgranular variant of acute promyelocytic leukemia with atypical morpho-cytochemical features and an early myeloid immunophenotype 463
Minimally differentiated acute myeloid leukemia (AML-MO): a distinct clinico-biologic entity with poor prognosis 457
AML-M0: A review of laboratory features and proposal of new diagnostic criteria 455
A novel t(11;12)(q23-24;q24) in a case of minimally-differentiated acute myeloid leukemia (AML-M0) 453
A case of SRSF2 mutation in chronic lymphocytic leukemia 453
Graft failure due to hemolytic uremic syndrome recurrence 452
Positive selection of CD34+ cells by immunoadsorption: factors affecting the final yield and hematopoietic recovery in patients with hematological malignancies and solid tumors 451
Autologous peripheral blood stem cell transplantation as first line treatment of multiple myeloma: an Italian multicenter study 448
A phase-II trial of all trans retinoic acid and low-dose cytosine arabinoside for the treatment of high-risk myelodysplastic syndromes 448
13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia 444
Consolidation and maintenance immunotherapy with rituximab improve clinical outcome in patients with B-cell chronic lymphocytic leukemia. 443
Clinical significance of CD38 expression in chronic lymphocytic leukemia 442
CD7 expression in acute myeloid leukemia 441
All-trans-retinoic acid plus low-doses of cytarabine for the treatment of poor-risk acute myeloid leukemias 440
Acute lymphoblastic leukemia subsequent to autoimmune hemolytic anemia: a case report 436
Analysis of the expression of adhesion molecules on CD34+ progenitors from bone marrow, umbilical cord blood and G-CSF mobilized peripheral blood 436
Comparison between conventional banding analysis and FISH screening with an AML specific set of probes in 260 patients 435
Biological profile of 23 cases of minimally differentiated acute myeloid leukemia (AML-MO) and its clinical implications 434
High expression levels of vla-4 (CD49d) on mobilised peripheral blood stem cells are associated with rapid engraftment in multiple myeloma patients receiving autologous transplant 432
Intensive treatment of patients age 60 years and older with de novo acute myeloid leukemia - Analysis of prognostic factors 432
Prognostic relevance of the expression of Tdt and CD7 in 335 cases of acute myeloid leukemia 432
Collection of peripheral progenitor cells: a comparison between Amicus and Cobe-Spectra blood cell separators 431
All-trans retinoic acid (ATRA) administration during pregnancy in relapsed acute promyelocytic leukemia 430
Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments 428
Surface-antigen expression profiling (SEP) in B-cell chronic lymphocytic leukemia (B-CLL): Identification of markers with prognostic relevance 427
Multiparametric analysis for the enumeration of CD34+ cells from bone marrow and stimulated peripheral blood 427
Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML) 426
Clinical relevance of minimal residual disease detection in adult acute myeloid leukemia 425
Leukocyte alkaline-phosphatase score in plasma-cell dyscrasias - correlation with disease severity and circulating levels of granulocyte-colony-stimulating factor 424
Bone marrow necrosis as a terminal complication of a very long-lasting polycythemia vera 423
Femoral catheters: safety and efficacy in peripheral blood stem cell collection 421
Response to B-cell-depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura 420
The kinetics of reduction of minimal residual disease impacts on duration of response and survival of patients with acute myeloid leukemia. 420
P-glycoprotein and terminal transferase expression identify prognostic subsets within cytogenetic risk classes in acute myeloid leukemia 420
Pure erythroid leukemia in advanced breast cancer. 420
Analysis of regulatory T cell changes in patients with idiopathic thrombocytopenic purpura receiving B-cell depleting therapy with rituximab 417
Clinical implications of cytokine and soluble receptor measurements in patients with newly-diagnosed aggressive non-Hodgkin's lymphoma 417
Molecular characterization of Ph' + hybrid acute leukemia 417
Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab 416
Biological features of acute myeloid leukemia in the elderly 416
Central Nervous System Involvement in Adult Acute Lymphoblastic Leukemia: Diagnostic Tools, Prophylaxis, and Therapy. 416
CD7 Expression in acute myeloid leukemia 414
Chronic lymphocytic leukemia-associated immune thrombocytopenia treated with rituximab: a retrospective study of 21 patients 412
Gelatinous degeneration of the bone marrow: two case reports showing different hematological features and clinical outcomes 411
Efficacy and safety of human leucocyte interferon-alpha treatment in patients younger than 60 years of age with polycythaemia vera 411
Minimally differentiated acute myeloid leukemia (AML-MO): Comparison of 25 cases with other French-American-British subtypes 411
Complete regression of cutaneous lesions of refractory Ph+ ALL after 4 weeks of treatment with BMS-354825 410
Hodgkin disease subsequent to follicular lymphoma on maintenance rituximab 410
Soluble factors levels in the initial staging of high-grade non-Hodgkin's lymphomas 410
P-glycoprotein and BCL-2 levels predict outcome in adult acute lymphoblastic leukaemia 409
Cutaneous involvement in multiple myeloma and bortezomib 409
Lecam1/Icam1 ratio identifies a distinct pattern on normal and myelodysplastic bone marrow CD34+ progenitors cells 409
Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia 409
Activation-induced cytidine deaminase and CD38 expression in B-cell chronic lymphocytic leukemia 408
The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: a retrospective multicentric GIMEMA experience 408
Monocytes/macrophages but not T lymphocytes are the major targets of the CCL3/CCL4 chemokines produced by CD38(+)CD49d(+) chronic lymphocytic leukaemia cells 408
Management of hematological malignancies in patients affected by renal failure 407
Diagnosis of acute myeloid leukemia and system Coulter VCS 407
Graft failure due to hemolytic uremic syndrome recurrence 406
Clinical implication of cytokine and soluble receptor measurements in patients with newly diagnosed aggressive non Hodgkin Lymphomas 406
AML-M0: a biological and clinical profile 405
Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia. 405
NOTCH1 mutations associate with low CD20 level in chronic lymphocytic leukemia: Evidence for a NOTCH1 mutation-driven epigenetic dysregulation 404
Discriminant function analysis as decision support system for the diagnosis of acute leukemia with a minimal four color screening panel and multiparameter flow cytometry immunophenotyping 402
IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemia. 401
How would I manage a sample submitted for flow cytometry analysis for suspicious chronic lymphocytic leukaemia 400
Chromosomal aberration of the 11q23 locus in acute leukemia and frequency of MLL gene translocation: results in 378 adult patients 399
Dismal Outcome of Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia after Azacitidine Failure in a Daily-Life Setting. 397
Unexplained severe Coombs-negative hemolytic anemia during treatment of refractory chronic lymphocytic leukemia with alemtuzumab. 396
FISH analysis for CML monitoring? 395
Analysis of treatment failure in patients with minimally differentiated acute myeloid leukemia (AML-M0) 395
Potential therapeutic role of antagomiR17 for the treatment of chronic lymphocytic leukemia. 395
Normal lymphocytes from leukemic samples as an internal quality control for fluorescence intensity in immunophenotyping of acute leukemias 393
High interleukin-6 plasma levels in acute promyelocytic leukemia 393
Minimally differentiated acute myeloid-leukemia (aml-mo): cytochemical, immunophenotypic and cytogenetic analysis of 19 cases 392
In vitro infection of leukemic bone marrow with HTLV-I generates immortalized cell lines expressing T or myeloid cell phenotype 391
ZAP-70 expression in B-cell chronic lymphocytic leukemia: evaluation by external (isotypic) or internal (T/NK cells) controls and correlation with IgV(H) mutations 391
Fluorescence in situ hybridization and conventional cytogenetics for the diagnosis of 11q23(+)/MLL+ translocation in leukaemia 391
Multiple myeloma shows no intra-disease clustering of immunoglobulin heavy chain genes. 391
Multidimensional flow cytometry for detection of minimal residual disease in acute myeloid leukemia 390
Clinical heterogeneity of idiopathic CD4+T lymphocytopenia 390
Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia 388
Mitoxantrone in combination with etoposide and cytarabine for treatment of poor prognosis acute non lymphoid leukemia patients 387
Biological pattern of AML-M0 versus AML-M1: Response 387
Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia 387
A scoring system based on the expression of six surface molecules allows the identification of three prognostic risk groups in B-cell chronic lymphocytic leukemia 386
Immunophenotypic characterization of IgVH3-72 B-cell chronic lymphocytic leukaemia (B-CLL) 386
CD49d expression in chronic lymphocytic leukemia: a prognostic parameter and a therapeutic target 385
Clinical significance of soluble p53 protein in B-cell chronic lymphocytic leukemia 385
Contribution of immunophenotypic and genotypic analysis to the diagnosis of acute leukemia 385
Tumor evolutionary directed graphs and the history of chronic lymphocytic leukemia 385
Cytogenetic and molecular diagnostic characterization combined to post-consolidation minimal residual disease assessment by flow-cytometry improves risk stratification in adult acute myeloid leukemia 384
Ibrutinib Inhibits VLA-4-Dependent Adhesion in CLL-Letter 384
Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia 384
Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation 383
P-glycoprotein expression in de novo acute myeloid leukemia 382
Totale 41.626
Salva come PNG Salva come JPEG
Categoria #
all - tutte 149.691
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 149.691
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.736 0 0 0 0 0 0 0 0 1.636 1.590 1.179 1.331
2020/202111.075 1.363 1.334 1.166 1.466 1.083 1.155 1.380 1.030 290 242 465 101
2021/20222.169 71 282 61 107 39 206 119 112 115 222 138 697
2022/20232.879 362 240 206 281 194 631 269 165 286 10 182 53
2023/2024875 101 35 39 15 101 297 44 29 19 11 14 170
2024/20253.155 152 1.210 582 250 61 187 400 207 106 0 0 0
Totale 76.955